2017
DOI: 10.3906/sag-1601-183
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of polyneuropathy and associated risk factors inchildren with type 1 diabetes mellitus

Abstract: Background/aim: Diabetes mellitus (DM) is one of the most common metabolic diseases seen in the world today. Diabetic neuropathy (DN) is a chronic complication of the disease that is rarely reported in children, since it has a relatively longer latency period. Our main objective in this study is to determine the incidence rate of DN in pediatric DM patients and assess the risk factors associated with DN.Materials and methods: Data from 111 patients from January 2011 to May 2014 were reviewed in a retrospective… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0
2

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 16 publications
0
3
0
2
Order By: Relevance
“…However, a study of children with type 1 diabetes showed reduced motor and sensory nerve conduction velocities (24%), and at least one neuropathic symptom (60%) or sign (58%) 9 . In another study, symptomatic neuropathy was present in 13.5% of patients, whereas 22.5% of patients had neurophysiological evidence of neuropathy 10 and 18% had impaired vibrotactile sense 11 . Furthermore, in one study, 36% of patients had more than two abnormal autonomic function tests, and 18.8% had severe autonomic neuropathy 12 .…”
Section: Introductionmentioning
confidence: 92%
“…However, a study of children with type 1 diabetes showed reduced motor and sensory nerve conduction velocities (24%), and at least one neuropathic symptom (60%) or sign (58%) 9 . In another study, symptomatic neuropathy was present in 13.5% of patients, whereas 22.5% of patients had neurophysiological evidence of neuropathy 10 and 18% had impaired vibrotactile sense 11 . Furthermore, in one study, 36% of patients had more than two abnormal autonomic function tests, and 18.8% had severe autonomic neuropathy 12 .…”
Section: Introductionmentioning
confidence: 92%
“…Терапия ДН у детей с СД I типа должна включать методы, влияющие на патогенез развития заболевания, а также симптоматическое лечение и профилактику прогрессирования ДН [1,19]. Нарушение обмена глюкозы служит важным фактором развития ДН, в связи с этим основным методом лечения и профилактики заболевания является строгий метаболический контроль с избеганием как гипергликемических, так и гипогликемических состояний [2,21,25].…”
Section: лечениеunclassified
“…Generally, children and adolescents do not have signs or symptoms of diabetic polyneuropathy 4–6 and screening tools recommended for adults, such as clinical examination and the Semmes‐Weinstein microfilament, are unreliable, especially in children 7,8 . Abnormalities in motor and sensory nerve conduction studies (NSC) have been reported in ~20%–34.5% of children with type 1 diabetes 9–12 . Due to the absence of clinical symptoms and signs, lack of good pediatric normative data, and technical challenges in performing quantitative sensory testing (QST) 12 and other neurophysiological assessments, the diagnosis of early diabetic neuropathy is challenging in children 13 …”
Section: Introductionmentioning
confidence: 99%
“…7,8 Abnormalities in motor and sensory nerve conduction studies (NSC) have been reported in $20%-34.5% of children with type 1 diabetes. [9][10][11][12] Due to the absence of clinical symptoms and signs, lack of good pediatric normative data, and technical challenges in performing quantitative sensory testing (QST) 12 and other neurophysiological assessments, the diagnosis of early diabetic neuropathy is challenging in children. 13 Although diabetic neuropathy is known to primarily affect large nerve fibers, small fiber impairment is also being observed, especially early during the subclinical phase.…”
Section: Introductionmentioning
confidence: 99%